Wikidata

(Q40505812)

English

Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting.

scientific article

In more languages

Statements

title
Combined epidermal growth factor receptor targeting with the tyrosine kinase inhibitor gefitinib (ZD1839) and the monoclonal antibody cetuximab (IMC-C225): superiority over single-agent receptor targeting (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15475436
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15475436%20AND%20SRC:MED&resulttype=core&format=json
retrieved
3 January 2020
author name string

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q40505812&oldid=1495970901"